This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

MDRP 2022 — Medicaid Drug Rebate Program Summit
Delivered as a Hybrid Event
October 12-14, 2022 | JW Marriott ChicagoChicago, IL

Michael Kvassay
Social Science Research Analyst and Team Leader at HHS Office of Inspector General


Michael Kvassay is a Social Science Research Analyst and Team Leader in the Baltimore Regional Office of Evaluation and Inspections, a component within the Office of Inspector General (OIG) for the U.S. Department of Health and Human Services (HHS). Michael joined OEI in 2015, and recently published a report examining the utilization of lower-cost hepatitis C drugs in Medicare Part D and how it affected Medicare and beneficiary spending. Other studies he has worked on include reports evaluating the Centers for Medicare & Medicaid Services’ oversight of reasonable assumptions in the Medicaid Drug Rebate Program, how high-expenditure orphan drugs are being used in Medicare, as well as Federal oversight of child welfare programs.

Agenda Sessions

  • OIG Updates: Audits and Case Studies from the Manufacturer Perspective